Advaxis, Inc. To Present At The 2nd Annual Sachs Cancer Bio Partnering & Investment Forum
3/13/2014 9:09:12 AM
PRINCETON, N.J., March 13, 2014 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq:ADXS), a biotechnology company developing the next generation of cancer immunotherapies, today announced that the company will present at the 2nd Annual Sachs Cancer Bio Partnering & Investment Forum on Wednesday, March 19 at the New York Academy of Sciences. Robert G. Petit, Ph.D., Chief Scientific Officer of Advaxis, will serve on an expert panel titled "Immunotherapies and Cancer Vaccines" at 11:45am and Daniel J. O'Connor, Chief Executive Officer of Advaxis, will present an update on the Company at 1:30pm.
Help employers find you! Check out all the jobs and post your resume.
comments powered by